December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Envoy Medical, Inc. - Class A Common Stock (NQ:COCH)

0.7174 -0.0135 (-1.85%)
Streaming Delayed Price Updated: 2:26 PM EDT, Aug 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Envoy Medical, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
White Bear Lake, Minnesota--(Newsfile Corp. - March 17, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing... 
Via Newsfile
News headline image
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device
White Bear Lake, Minnesota--(Newsfile Corp. - March 12, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing... 
Via Newsfile
News headline image
Envoy Medical to Participate in the 37th Annual ROTH Conference
White Bear Lake, Minnesota--(Newsfile Corp. - March 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing... 
Via Newsfile
News headline image
First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant
White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health... 
Via Newsfile
News headline image
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio
White Bear Lake, Minnesota--(Newsfile Corp. - February 14, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health... 
Via Newsfile
Topics Intellectual Property
News headline image
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study
White Bear Lake, Minnesota--(Newsfile Corp. - December 19, 2024) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health... 
Via Newsfile
News headline image
Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
Envoy Medical to Present at the LD Micro Main Event XVII
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem® Device
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
Envoy Medical Awarded Patent for Recharge System used with Implantable Battery
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying ↗
 
Via Benzinga
News headline image
Envoy Medical Secures Lending Facility of $10M
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q2 2024 ↗
COCH stock results show that Envoy Medical missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
Envoy Medical Announces Inclusion in the Russell Microcap Index
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
Newly Published Peer-Reviewed Article Highlights Advances in Fully Implanted Cochlear Implant Technology
From Envoy Medical, Inc
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q1 2024 ↗
COCH stock results show that Envoy Medical missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.